Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP.

Slides:



Advertisements
Similar presentations
Testing Relational Database
Advertisements

COMPANY MAINTENANCE MANUAL
Why are things coloured ?. Beam of white light hits Homers head Yellow light reflects in all directions Blue light reflects in all directions Beam of.
Radiopharmaceutical Production
Radiopharmaceutical Production
Oxygen And Acetylene Safety
Radiopharmaceutical Production Filter integrity test STOP.
SPECTROPHOTOMETRY IN BIOTECHNOLOGY
Radiopharmaceutical Production
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
T. E. Potok - University of Tennessee Software Engineering Dr. Thomas E. Potok Adjunct Professor UT Research Staff Member ORNL.
World Health Organization
World Health Organization
Module 12 – part 2 | Slide 1 of 35 January 2006 Basic Principles of GMP Documentation Part 2 15.
Hazard Analysis and Critical Control Points
Unit 6 – Acids and Bases.  Indicators are dyes that change colour under varying conditions of acidity.  Although not as accurate as instruments such.
Parenteral quality control
Character of serial dosage forms: sterility and freedom from particulate matter are common character of serial dosage forms. Parenteral should be pyrogen.
Chemical synthesis Lesson 5. Learning objective: To understand how the purity of a sample can be determined by performing a titration. Must: Give examples.
Amal Alghamdi 346 MIC.  Aim: to measure the chlorides in soil.  Materials:  Soil samples  White porcelain crucible/dish  Burette  Dropper  Beakers.
Radiopharmaceutical Production
Introduction to Statistical Inferences
Basic Principles of GMP
Organic Compounds Lab Procedure.
Radiopharmaceutical Production
Colorimetry & Spectrophotometry.
John R. MurphyACPS 10/ Zero Tolerance Criteria Do Not Assure Product Quality John R. Murphy, Ph.D. Meeting of the Advisory Committee for Pharmaceutical.
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials.
Design Visualization and Character Development Artistic Rendering Using Illustration Software.
Calderglen High School.
Important informations
SPECTROPHOTOMETRY IN BIOTECHNOLOGY
Building Dependable Distributed Systems Chapter 1 Wenbing Zhao Department of Electrical and Computer Engineering Cleveland State University
Quality Assurance How do you know your results are correct? How confident are you?
Radiopharmaceutical Production Quality Control Testing Product Stability STOP.
17.1 – The Common-Ion Effect The Common Ion Effect = the suppression of the ionization of a weak acid or base by the presence of a common ion from a strong.
1 ON-SITE SUPERVISION – CHECKLISTS. 2 Checklists Serve as documentation of the visit and record of current conditions and actions needed Help carrying.
Radiopharmaceutical Production Sub STOP. Radionuclidic purity Radionuclidic purity may be defined as the fraction of total radioactivity that is present.
Trials and Tribulations of Developing a Method for Quantification of Aerosol Chamber Concentration Richard Snell, Dose Concentration Analysis GSK.
Radiopharmaceutical Production
Sterile product validation
CHM 101/102 Laboratory Manual Qualitative Analysis: Group I General Chemistry 101/102 Laboratory Manual University of North Carolina at Wilmington.
Red Cabbage Lab tacid/indicate.htm has very nice cartoons to explain acids, bases, and indicators.
AP Free Response Questions 2003
Radiopharmaceutical Production Radionuclidic identity STOP.
Radiopharmaceutical Production
Radiopharmaceutical Production
Radiopharmaceutical Production Radioassay STOP. Radiopharmaceutical Production Radioassay Example STOP Radioassay Acceptance Criteria: The product label.
Precipitation Titrations
SPECTROPHOTOMETRY IN BIOTECHNOLOGY. LIGHT IS A TYPE OF ELECTROMAGNETIC RADIATION Imagine electromagnetic radiation like waves on a pond – But instead.
Acids and Bases Vanderbilt Student Volunteers for Science Training Presentation Fall 2015 VINSE/TnScore.
Radiopharmaceutical Production
You will work in groups of 3
Quality assurance for Manufacturing Dressed Cavities for SPS prototype cryomodule C. Parente (HL-LHC Technical Quality Officer) Date:
Laboratory equipment Lecture (4).
2017 Mini-Bioman Drug Product Manufacturing Day 2
Testing foods for starch.
Jenn Sather, Piper Powelson, Kate Horton
Title Layout Subtitle.
Software testing.
N 4 Nuclear Chemistry and Analysis
N 3- 4 Nuclear Chemistry and Analysis
Light Vehicle Diesel Engines
Are you experienced in colour composition?! OK,
8/10/2019 VISUAL APPEARANCE TEST – “WHITE BUCKET” Date Time Initials
Radiopharmaceutical Production
Radiopharmaceutical Production
Radiopharmaceutical Production
SB Installation Tools Installation Tools
Presentation transcript:

Radiopharmaceutical Production Quality Control Testing Visual Inspection STOP

Visual Inspection The radiopharmaceutical should be inspected visually to check for the color and presence of any particulate matter. Contents Acceptance Criteria Discussion Procedure STOP

Radiopharmaceutical Production QC Testing Visual Inspection Contents Acceptance Criteria Discussion Procedure STOP Acceptance Criteria Acceptance Criteria: The product should be clear, colorless and free from particulate matter. The test should be completed on every batch prior to release of product. Procedure: Hold the test sample in the path of a strong light beam and against a white and a black background to inspect colour and presence of particulate matter. For sake of radiation protection, the vial content is viewed through a leaded glass. Non-tinted glass or indirect viewing using a mirror or video camera is preferred to eliminate the possibility of false observation of colour in the solution.

Radiopharmaceutical Production QC Testing Visual Inspection Contents Acceptance Criteria Discussion Procedure STOP Discussion Discussion: A slight yellow color in the preparation is acceptable according to IP and Ph. Eur. specifications due to the fact that the sample is often viewed through tinted glass. However, experience shows that FDG preparations are generally colorless. Therefore, ‘slightly yellow’ color in the product should be treated with caution as this occurrence indicates the likely presence of impurities arising during manufacturing. Visual inspection is a measure of the process performance. Presence of particulate matter in the product indicates possible failure at various stages of manufacturing including: failure of the sterilizing filtration, inadequate cleaning and control of glassware and components, inadequate environmental control during assembly of reagents in pre-installation stage, and perhaps operator error.

Radiopharmaceutical Production QC Testing Visual Inspection Contents Acceptance Criteria Discussion Procedure STOP Procedure Note: A closer visual inspection may be performed on the reserve sample several half-lives post-production. Procedure: Hold the test sample in the path of a strong light beam and against a white and a black background to inspect colour and presence of particulate matter. For sake of radiation protection, the vial content is viewed through a leaded glass. Non-tinted glass or indirect viewing using a mirror or video camera is preferred to eliminate the possibility of false observation of colour in the solution. Link to demonstration

Return to Main Menu